ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
115.50
-1.48 (-1.27%)
At close: Mar 13, 2026, 4:00 PM EDT
119.76
+4.26 (3.69%)
Pre-market: Mar 16, 2026, 6:25 AM EDT
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $8.99 billion as of March 16, 2026. Its market cap has increased by 1,799.40% in one year.
Market Cap
8.99B
Enterprise Value
8.38B
1-Year Change
1,799.40%
Ranking
Category
Stock Price
$115.50
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $8.99B, an increase of 3,886.95%. That is a compound annual growth rate of 41.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 9.01B | -18.10% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 10.71B |
| Madrigal Pharmaceuticals | 10.20B |
| ImmunityBio | 8.63B |
| Praxis Precision Medicines | 8.19B |
| Axsome Therapeutics | 7.98B |
| Bio-Techne | 7.96B |
| Vaxcyte | 7.86B |
| Arrowhead Pharmaceuticals | 7.71B |